share_log

Cantor Fitzgerald Reiterates Overweight on Affimed, Maintains $7 Price Target

Benzinga ·  Sep 7, 2023 10:30

Cantor Fitzgerald analyst Li Watsek reiterates Affimed (NASDAQ:AFMD) with a Overweight and maintains $7 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment